Tryptophan degradation in women with breast cancer: a pilot study (Q33912950)

30 July 2017

title

Tryptophan degradation in women with breast cancer: a pilot study (English)

1 reference

30 July 2017

Debra E Lyon

1

1 reference

30 July 2017

Jeanne M Walter

2

1 reference

30 July 2017

Angela R Starkweather

3

1 reference

30 July 2017

Christine M Schubert

4

1 reference

30 July 2017

Nancy L McCain

5

1 reference

30 July 2017

publication date

26 May 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

4

1 reference

30 July 2017

page(s)

156

1 reference

Creative Commons Attribution 2.0 Generic

30 July 2017

copyright license

start time

26 May 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Cytokine comparisons between women with breast cancer and women with a negative breast biopsy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Endogenous kynurenines as targets for drug discovery and development

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Cognitive function after chemotherapy in adults with solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Monitoring tryptophan metabolism in chronic immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Tryptophan breakdown pathway in bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Association between increased tryptophan degradation and depression in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Whole blood serotonin in autistic and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1756-0500-4-156

Immune system modulation in patients with malignant and benign breast disorders: tryptophan degradation and serum neopterin

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Study of indoleamine 2,3-dioxygenase expression in patients with breast cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Symptom clusters in breast cancer across 3 phases of the disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3117722

Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human females

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21615916

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21615916

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1756-0500-4-156

1 reference

Dimensions Publication ID

30 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1756-0500-4-156

9 September 2019

0 references

1 reference

30 July 2017

1 reference